- Home
- KRMD vs SENS Comparison
KRMD vs SENS Comparison
Compare KRMD & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- SENS
- Stock Information
- Founded
- KRMD 1980
- SENS 1996
- Country
- KRMD United States
- SENS United States
- Employees
- KRMD N/A
- SENS N/A
- Industry
- KRMD Medical/Dental Instruments
- SENS Industrial Machinery/Components
- Sector
- KRMD Health Care
- SENS Industrials
- Exchange
- KRMD Nasdaq
- SENS Nasdaq
- Market Cap
- KRMD 192.3M
- SENS 360.5M
- IPO Year
- KRMD N/A
- SENS N/A
- Fundamental
- Price
- KRMD $4.23
- SENS $7.06
- Analyst Decision
- KRMD Strong Buy
- SENS Strong Buy
- Analyst Count
- KRMD 4
- SENS 6
- Target Price
- KRMD $4.63
- SENS $28.67
- AVG Volume (30 Days)
- KRMD 76.9K
- SENS 692.4K
- Earning Date
- KRMD 11-12-2025
- SENS 11-05-2025
- Dividend Yield
- KRMD N/A
- SENS N/A
- EPS Growth
- KRMD N/A
- SENS N/A
- EPS
- KRMD N/A
- SENS N/A
- Revenue
- KRMD $36,848,451.00
- SENS $25,466,000.00
- Revenue This Year
- KRMD $21.08
- SENS $62.96
- Revenue Next Year
- KRMD $16.37
- SENS $72.62
- P/E Ratio
- KRMD N/A
- SENS N/A
- Revenue Growth
- KRMD 19.57
- SENS 5.94
- 52 Week Low
- KRMD $1.86
- SENS $5.00
- 52 Week High
- KRMD $5.05
- SENS $28.00
- Technical
- Relative Strength Index (RSI)
- KRMD 56.97
- SENS 79.72
- Support Level
- KRMD $3.92
- SENS $6.56
- Resistance Level
- KRMD $4.32
- SENS $8.73
- Average True Range (ATR)
- KRMD 0.18
- SENS 0.39
- MACD
- KRMD 0.02
- SENS 0.78
- Stochastic Oscillator
- KRMD 64.71
- SENS 80.24
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.